Drive-Through Mass-Vaccination Clinics Could Stem COVID-19 Crisis
Researchers Use Data from the H1N1 Pandemic to Model Pathway to Achieve Faster Vaccination to Alter COVID-19 Trajectory Although waiting times in walk-up clinics are…
Vaccine
Just a Single Dose of COVID-19 Vaccine Provokes Strong Immune Response in Those Previously Infected
Strong response detected regardless of duration between infection and vaccination; multi-ethnic groups exhibit similar response. Although clinical trial data are encouraging, real-world evidence with regard…
The Most Rapid Vaccine Rollout in History: How Researchers Developed COVID-19 Vaccines So Quickly
Vaccine development is typically measured in years, not months. But as the COVID-19 pandemic rages on, scientists are racing the clock—and breaking records—to develop an…
Immune Boosting Nasal Spray: Protects Against COVID-19, Is Also Effective Against the Common Cold
Research into a new drug that primes the immune system in the respiratory tract and is in development for COVID-19 shows it is also effective…
Building Equity Into COVID-19 Vaccine Distribution: How Therapies Can Be Allocated Fairly
MIT economist works to show how therapies can be allocated fairly; states are now applying the method in their efforts. Two of the studies described…
125,000 Lives Could Be Saved in the U.S. if 50% Initiate COVID Vaccination by March 1
A new report combining forecasting and expert prediction data, predicts that 125,000 lives could be saved by the end of 2021 if 50% or more…
Depression and Stress Could Dampen Efficacy of COVID-19 Vaccines: Interventions Could Boost Immunity
Health behaviors and emotional stressors can alter the body’s ability to develop an immune response to vaccines, including—potentially—the new COVID-19 vaccines. Simple interventions, including exercising…
New Results From Monkeys Infected With SARS-CoV-2 Suggest COVID-19 Vaccines Will Be Successful
Rhesus macaques develop promising immune response to SARS-CoV-2; Results suggest lasting immunity after infection. In a promising result for the success of vaccines against COVID-19,…
Hold Up – New COVID-19 Model Shows Little Benefit in Vaccinating High-Risk Individuals First
The World Health Organization reports that as of January 19, 2021, there are approximately 94 million cases of COVID-19 globally, with over 2 million deaths….
Why RNA Vaccines for COVID-19 Raced to the Front of the Pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells. Developing and testing a new vaccine typically takes…
New COVID-19 Vaccine: Nanoparticle Immunization Technology Could Protect Against Many Strains of Coronaviruses
Method presents the immune system with several different coronaviruses at once. The SARS-CoV-2 virus that is causing the COVID-19 pandemic is just one of many…
New Research Finds Colleges Can Prevent 96% of COVID-19 Infections Without Vaccines
The combined effectiveness of three COVID-prevention strategies on college campuses — mask-wearing, social distancing, and routine testing — are as effective in preventing coronavirus infections…
Stanford’s Single-Dose Nanoparticle Vaccine for COVID-19
Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature. Before the pandemic, the lab…
Why Declining Antibodies Don’t Spell Disaster for Long-Lasting COVID-19 Immunity
Protective immunity against SARS-CoV-2 could last eight months or more. New data suggest that nearly all COVID-19 survivors have the immune cells necessary to fight…
COVID-19: What Black Americans, Women and Conservatives Have in Common
Black Americans, women, conservatives more hesitant to trust COVID-19 vaccine. Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be…
U.S. Needs Clear COVID-19 Vaccine Distribution Strategy to Defeat Coronavirus
An opinion piece published in The BMJ — a peer-reviewed medical journal by the British Medical Association — written by Nina Schwalbe in the Heilbrunn…
94.1% Efficacy Shown in Moderna COVID-19 Vaccine Trial
Results from the primary analysis of the ongoing phase 3 clinical trial demonstrate efficacy in preventing symptomatic COVID-19 infections and severe illness. A peer-reviewed paper…
Biggest Vaccination Effort in U.S. History, yet Some States May Lack Facilities for Administering COVID-19 Vaccine to Residents
University of Pittsburgh School of Pharmacy and West Health Policy Center develop mapping-tool to identify counties where residents may face access issues. As the biggest…
